Searched for
DIGITAL DRUG REGULATORY SYSTEM
Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...- Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soonIndian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...
- Tokenised gold: A new way to invest in gold or a risky bet? What Indian investors need to know before investingTokenised gold is emerging as a new investment option in India. It uses blockchain to represent physical gold digitally. Investors can trad...
- Bharti Airtel's Rahul Vatts named COAI Chairperson for 2026-27Rahul Vatts of Bharti Airtel will lead COAI as Chairperson for 2026-27. Ravi Gandhi of Reliance Jio will be Vice-Chairperson. The announcem...
- Agentic AI adoption drives stronger governance oversight, risk controlsIndia first: Firms prioritise domestic industry guidelines over global frameworks, remain confident on DPDP
- India’s MSMEs are no longer digitising for compliance alone: Tally’s Tejas GoenkaAs MSMEs accelerate their digital transformation journey, technology is becoming central to growth, efficiency, and resilience. Tejas Goenk...
- Quantum tech firm EigenQ to go public in $3 billion SPAC dealQuantum tech firm EigenQ is set to go public through a merger with Silicon Valley Acquisition. The deal values EigenQ at approximately $3 b...
- Sebi warns of no regulatory recourse for investors trading in unlisted securitiesSebi has cautioned investors against trading unlisted securities through unauthorized websites and electronic platforms. The regulator said...
- Government prescribes end to over-the-counter sale of cough syrupsEven in small villages with a population of less than 1,000, where certain remedies including cough syrups were allowed to be sold without ...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- Why the ET Most Innovative AI Product Awards 2026 are spotlighting industry-specific innovationThe most impactful AI products of 2026 aren't built to do everything; they're built to solve one problem exceptionally well. The ET Most In...
- Centre mandates prescription for syrup-based medicinesChemists must now have a doctor's prescription to sell cough syrups. The government has changed the Drugs Rules, 1945. This stops over-the-...
- India's next telecom battle could be fought on highways, with connected carsIndia's telecom wars have traditionally revolved around spectrum, towers and tariffs. But a new consultation paper by TRAI on Vehicle-to-Ev...
- Telcos, businesses spar over calls, SMS consent regimeTelecom companies and banks are in a dispute over India's new digital consent rules for commercial messages. Major telecom players want con...
- Agentic AI adoption drives stronger governance oversight, risk controlsIndian companies are prioritising local AI rules over international ones. They are focusing on ethics, identity, and privacy as AI adoption...
- RBI plans simpler cross-border payment approvals to boost MSMEs, exporters: EY reportThe Reserve Bank of India (RBI) is looking to simplify cross-border payment approvals and reduce regulatory friction for businesses and exp...
- GST@9: Building a more seamless, certainty-driven input tax credit frameworkA more balanced and predictable approach can help safeguard revenue, reduce disputes, enhance taxpayer confidence, and create a more effici...
- UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
- Regulators tighten GMP oversight of pharma plantsSeveral states have constituted dedicated multi-member teams to ensure no facility slips through the cracks before a GMP Certificate is iss...
- Drug companies directed to step up vigil on adverse reactionsIndia's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes am...
Load More
